AKT1 and pulmonary fibrosis: Interestingly, prostaglandin E2, an endogenous inhibitor of FOXM1, drives AKT and FOXO3a phosphorylation through the modulation of the EP2/cAMP signaling pathway, thereby inhibiting the process of pulmonary fibrosis in mice [78].